Biomarkers in Cervical Cancer
Cervical cancer, a potentially preventable disease, remains the second most common malignancy in women worldwide. Human papillomavirus (HPV) is the single most important etiological agent in cervical cancer, contributing to neoplastic progression through the action of viral oncoproteins, mainly E6 a...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2006-01-01
|
| Series: | Biomarker Insights |
| Subjects: | |
| Online Access: | http://la-press.com/article.php?article_id=12 |
| _version_ | 1828155749610553344 |
|---|---|
| author | Eun-Kyoung Yim Jong-Sup Park |
| author_facet | Eun-Kyoung Yim Jong-Sup Park |
| author_sort | Eun-Kyoung Yim |
| collection | DOAJ |
| description | Cervical cancer, a potentially preventable disease, remains the second most common malignancy in women worldwide. Human papillomavirus (HPV) is the single most important etiological agent in cervical cancer, contributing to neoplastic progression through the action of viral oncoproteins, mainly E6 and E7. Cervical screening programs using Pap smear testing have dramatically improved cervical cancer incidence and reduced deaths, but cervical cancer still remains a global health burden. The biomarker discovery for accurate detection and diagnosis of cervical carcinoma and its malignant precursors (collectively referred to as high-grade cervical disease) represents one of the current challenges in clinical medicine and cytopathology. |
| first_indexed | 2024-04-11T22:58:40Z |
| format | Article |
| id | doaj.art-8ac011509d7f4003997f355785eeb667 |
| institution | Directory Open Access Journal |
| issn | 1177-2719 |
| language | English |
| last_indexed | 2024-04-11T22:58:40Z |
| publishDate | 2006-01-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Biomarker Insights |
| spelling | doaj.art-8ac011509d7f4003997f355785eeb6672022-12-22T03:58:16ZengSAGE PublishingBiomarker Insights1177-27192006-01-011215225Biomarkers in Cervical CancerEun-Kyoung YimJong-Sup ParkCervical cancer, a potentially preventable disease, remains the second most common malignancy in women worldwide. Human papillomavirus (HPV) is the single most important etiological agent in cervical cancer, contributing to neoplastic progression through the action of viral oncoproteins, mainly E6 and E7. Cervical screening programs using Pap smear testing have dramatically improved cervical cancer incidence and reduced deaths, but cervical cancer still remains a global health burden. The biomarker discovery for accurate detection and diagnosis of cervical carcinoma and its malignant precursors (collectively referred to as high-grade cervical disease) represents one of the current challenges in clinical medicine and cytopathology.http://la-press.com/article.php?article_id=12Cervical cancerHuman papillomavirus (HPV)biomarker |
| spellingShingle | Eun-Kyoung Yim Jong-Sup Park Biomarkers in Cervical Cancer Biomarker Insights Cervical cancer Human papillomavirus (HPV) biomarker |
| title | Biomarkers in Cervical Cancer |
| title_full | Biomarkers in Cervical Cancer |
| title_fullStr | Biomarkers in Cervical Cancer |
| title_full_unstemmed | Biomarkers in Cervical Cancer |
| title_short | Biomarkers in Cervical Cancer |
| title_sort | biomarkers in cervical cancer |
| topic | Cervical cancer Human papillomavirus (HPV) biomarker |
| url | http://la-press.com/article.php?article_id=12 |
| work_keys_str_mv | AT eunkyoungyim biomarkersincervicalcancer AT jongsuppark biomarkersincervicalcancer |